Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Embecta Corp.EMBC · Entity 5950 | Director · President and CEO | August 12, 2026 | August 13, 2026 |
| ZIMMER BIOMET HOLDINGS, INC.ZBH · Entity 3278 | Director | September 30, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Embecta Corp.
Report date August 12, 2026 · Filed August 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 804,918.728 |
Reported balance
After 2026-08-12 transaction · row 1
1 source rowRow 1 · 2026-08-12 · Purchase · Acquired 30,000 · Balance 804,918.728 |
ZIMMER BIOMET HOLDINGS, INC.
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $89.85 | Direct | 3,171.359 |
Reported balance
After 2026-09-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 173.901 · Balance 3,171.359 F1: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4: Includes 7.276 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
F2: The Conversion or Exercise Price of Derivative Security is 1-for-1.
F3: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
F4: Includes 7.276 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 3, 2026 00:12 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 173.901 | $0.00 Strike: $89.85 | $0.00 |
DisclosureSEC source: 0001910621-26-000010 · form4-10022026_081024.xml · derivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,171.359 Underlying: Common Stock · 173.901 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 7.276 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| August 12, 2026 Filed Aug 13, 2026 14:50 UTC | Embecta Corp. EMBC · Entity 5950 | PurchaseCommon Stock | 30,000 | $4.70 | $140,937.00 |
DisclosureSEC source: 0000947871-26-000789 · ownership.xml · nonDerivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 804,918.728 Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 21:43 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 180.323 | $0.00 Strike: $86.65 | $0.00 |
DisclosureSEC source: 0001910621-26-000008 · form4-07022026_090727.xml · derivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,990.182 Underlying: Common Stock · 180.323 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:11 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 1,517.274 | $0.00 | $0.00 |
DisclosureSEC source: 0001910621-26-000006 · form4-05272026_080533.xml · derivative · entry 2 Kurdikar Devdatt · CIK 0001910621 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,922.072 Underlying: Common Stock · 1,517.274 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:11 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 875.35 | $0.00 Strike: $85.68 | $0.00 |
DisclosureSEC source: 0001910621-26-000006 · form4-05272026_080533.xml · derivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,809.859 Underlying: Common Stock · 875.35 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 5.662 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:16 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 154.356 | $0.00 Strike: $89.08 | $0.00 |
DisclosureSEC source: 0001910621-26-000004 · form4-04022026_080411.xml · derivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,928.847 Underlying: Common Stock · 154.356 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 4.508 phantom stock units accrued on January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:06 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 152.22 | $0.00 Strike: $90.33 | $0.00 |
DisclosureSEC source: 0001910621-26-000002 · form4-01052026_090111.xml · derivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,769.983 Underlying: Common Stock · 152.22 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 3.876 phantom stock units accrued on October 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| November 26, 2025 Filed Dec 2, 2025 02:17 UTC | Embecta Corp. EMBC · Entity 5950 | Tax withholdingCommon Stock | 128,630 | $12.57 | $1,616,879.10 |
DisclosureSEC source: 0000947871-25-001050 · ownership.xml · nonDerivative · entry 3 Kurdikar Devdatt · CIK 0001910621 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 774,918.728 F3 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I and performance-based restricted stock units awarded to the reporting person pursuant to the Plan. F1 · balance_after: The number of shares reported in Column 5 of Table I includes shares received by the reporting person as stock dividends. Read SEC document |
| November 26, 2025 Filed Dec 2, 2025 02:17 UTC | Embecta Corp. EMBC · Entity 5950 | GrantCommon Stock | 103,626 | $0.00 | $0.00 |
DisclosureSEC source: 0000947871-25-001050 · ownership.xml · nonDerivative · entry 2 Kurdikar Devdatt · CIK 0001910621 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 903,548.728 F2 · shares: Shares acquired upon the certification of performance conditions applicable to performance-based restricted stock units awarded to the reporting person pursuant to the Embecta 2022 Employee and Director Equity-Based Compensation Plan (the "Plan"). F1 · balance_after: The number of shares reported in Column 5 of Table I includes shares received by the reporting person as stock dividends. Read SEC document |
| November 26, 2025 Filed Dec 2, 2025 02:17 UTC | Embecta Corp. EMBC · Entity 5950 | GrantCommon Stock | 288,386 | $0.00 | $0.00 |
DisclosureSEC source: 0000947871-25-001050 · ownership.xml · nonDerivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 799,922.728 F1 · balance_after: The number of shares reported in Column 5 of Table I includes shares received by the reporting person as stock dividends. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 21:19 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 140.163 | $0.00 Strike: $98.10 | $0.00 |
DisclosureSEC source: 0001910621-25-000004 · form4-10022025_091026.xml · derivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,613.887 Underlying: Common Stock · 140.163 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 3.428 phantom stock units accrued on July 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:26 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 150.916 | $0.00 Strike: $91.11 | $0.00 |
DisclosureSEC source: 0001062993-25-012452 · form4.xml · derivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,470.296 Underlying: Common Stock · 150.916 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 22:48 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 1,404.798 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-010731 · form4.xml · derivative · entry 2 Kurdikar Devdatt · CIK 0001910621 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,404.798 Underlying: Common Stock · 1,404.798 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 22:48 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 810.46 | $0.00 Strike: $92.54 | $0.00 |
DisclosureSEC source: 0001062993-25-010731 · form4.xml · derivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,319.38 Underlying: Common Stock · 810.46 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: These units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: These units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 1.192 phantom stock units accrued on April 30, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 20:16 UTC | Embecta Corp. EMBC · Entity 5950 | Tax withholdingCommon Stock | 39,592 | $12.00 | $475,104.00 |
DisclosureSEC source: 0000947871-25-000367 · ownership.xml · nonDerivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 499,582.278 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. F2 · balance_after: The number of shares reported in Column 5 of Table I includes shares received by the reporting person as stock dividends. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 122.211 | $0.00 Strike: $112.51 | $0.00 |
DisclosureSEC source: 0001062993-25-006815 · form4.xml · derivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 507.728 Underlying: Common Stock · 122.211 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 0.556 phantom stock units accrued January 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:12 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 130.048 | $0.00 Strike: $105.73 | $0.00 |
DisclosureSEC source: 0001062993-25-000148 · form4.xml · derivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 384.961 Underlying: Common Stock · 130.048 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 0.564 phantom stock units accrued October 31, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| November 26, 2024 Filed Nov 29, 2024 18:29 UTC | Embecta Corp. EMBC · Entity 5950 | Tax withholdingCommon Stock | 48,956 | $18.70 | $915,477.20 |
DisclosureSEC source: 0000947871-24-000966 · ownership.xml · nonDerivative · entry 2 Kurdikar Devdatt · CIK 0001910621 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 531,239.788 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. F2 · balance_after: The number of shares reported in Column 5 of Table I includes shares received by the reporting person as stock dividends. Read SEC document |
| November 26, 2024 Filed Nov 29, 2024 18:29 UTC | Embecta Corp. EMBC · Entity 5950 | GrantCommon Stock | 187,166 | $0.00 | $0.00 |
DisclosureSEC source: 0000947871-24-000966 · ownership.xml · nonDerivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 580,195.788 F2 · balance_after: The number of shares reported in Column 5 of Table I includes shares received by the reporting person as stock dividends. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:21 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 127.598 | $0.00 Strike: $107.76 | $0.00 |
DisclosureSEC source: 0001062993-24-017253 · form4.xml · derivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254.349 Underlying: Common Stock · 127.598 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 20:52 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 126.751 | $0.00 Strike: $108.48 | $0.00 |
DisclosureSEC source: 0001062993-24-013337 · form4.xml · derivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126.751 Underlying: Common Stock · 126.751 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| April 04, 2024 Filed Apr 8, 2024 20:32 UTC | Embecta Corp. EMBC · Entity 5950 | Tax withholdingCommon Stock | 4,535 | $12.78 | $57,957.30 |
DisclosureSEC source: 0000947871-24-000359 · ownership.xml · nonDerivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 388,005.2 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. F2 · balance_after: The number of shares reported in Column 5 of Table I includes shares received by the reporting person as stock dividends. Read SEC document |
| February 11, 2024 Filed Feb 13, 2024 21:31 UTC | Embecta Corp. EMBC · Entity 5950 | Tax withholdingCommon Stock | 17,165 | $16.26 | $279,102.90 |
DisclosureSEC source: 0000947871-24-000131 · ownership.xml · nonDerivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 389,940.3 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| November 26, 2023 Filed Nov 29, 2023 01:16 UTC | Embecta Corp. EMBC · Entity 5950 | Tax withholdingCommon Stock | 18,431 | $17.49 | $322,358.19 |
DisclosureSEC source: 0000947871-23-001112 · ownership.xml · nonDerivative · entry 2 Kurdikar Devdatt · CIK 0001910621 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 405,034 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| November 26, 2023 Filed Nov 29, 2023 01:16 UTC | Embecta Corp. EMBC · Entity 5950 | GrantCommon Stock | 178,674 | $0.00 | $0.00 |
DisclosureSEC source: 0000947871-23-001112 · ownership.xml · nonDerivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 423,465 Read SEC document |
| August 10, 2023 Filed Aug 10, 2023 21:11 UTC | Embecta Corp. EMBC · Entity 5950 | PurchaseCommon Stock | 5,000 | $21.81 | $109,050.00 |
DisclosureSEC source: 0001209191-23-045320 · doc4.xml · nonDerivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 244,791 Read SEC document |
| April 04, 2023 Filed Apr 5, 2023 22:24 UTC | Embecta Corp. EMBC · Entity 5950 | Tax withholdingCommon Stock | 4,875 | $27.36 | $133,380.00 |
DisclosureSEC source: 0001209191-23-023443 · doc4.xml · nonDerivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 239,451 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| April 04, 2023 Filed Apr 26, 2023 20:27 UTC Amendment | Embecta Corp. EMBC · Entity 5950 | Tax withholdingCommon Stock | 4,535 | $27.36 | $124,077.60 |
DisclosureSEC source: 0001209191-23-025681 · doc4a.xml · nonDerivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 239,791 F1 · shares: The Reporting Person previously filed a Form 4 that reported 4,875 shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. However, it was subsequently determined that the Reporting Person's withholding taxes were overwithheld, which was corrected on April 25, 2023. As such, the number of shares reported in Table I, Column 4 have been reduced to 4,535 shares to reflect the number of shares withheld. Read SEC document |
| February 11, 2023 Filed Feb 13, 2023 21:30 UTC | Embecta Corp. EMBC · Entity 5950 | Tax withholdingCommon Stock | 2,109 | $28.51 | $60,127.59 |
DisclosureSEC source: 0001209191-23-008731 · doc4.xml · nonDerivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,326 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| November 26, 2022 Filed Nov 29, 2022 22:09 UTC | Embecta Corp. EMBC · Entity 5950 | Tax withholdingCommon Stock | 4,428 | $33.04 | $146,301.12 |
DisclosureSEC source: 0001209191-22-058962 · doc4.xml · nonDerivative · entry 2 Kurdikar Devdatt · CIK 0001910621 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,435 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| November 26, 2022 Filed Nov 29, 2022 22:09 UTC | Embecta Corp. EMBC · Entity 5950 | GrantCommon Stock | 83,233 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-058962 · doc4.xml · nonDerivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,863 Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 17:46 UTC | Embecta Corp. EMBC · Entity 5950 | GrantStock Appreciation Rights · Derivative | 39,074 | $0.00 Strike: $31.40 | $0.00 |
DisclosureSEC source: 0001209191-22-023439 · doc4.xml · derivative · entry 4 Kurdikar Devdatt · CIK 0001910621 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,196 Underlying: Common Stock · 39,074 shares Expires 2032-04-04 F1 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning April 4, 2023. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 17:46 UTC | Embecta Corp. EMBC · Entity 5950 | GrantStock Appreciation Rights · Derivative | 65,122 | $0.00 Strike: $31.40 | $0.00 |
DisclosureSEC source: 0001209191-22-023439 · doc4.xml · derivative · entry 3 Kurdikar Devdatt · CIK 0001910621 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,122 Underlying: Common Stock · 65,122 shares Expires 2032-04-04 Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 17:46 UTC | Embecta Corp. EMBC · Entity 5950 | GrantCommon Stock | 26,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023439 · doc4.xml · nonDerivative · entry 2 Kurdikar Devdatt · CIK 0001910621 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,171 Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 17:46 UTC | Embecta Corp. EMBC · Entity 5950 | GrantCommon Stock | 65,122 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023439 · doc4.xml · nonDerivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,122 Read SEC document |
| April 04, 2022 Filed May 12, 2022 22:28 UTC Amendment | Embecta Corp. EMBC · Entity 5950 | GrantStock Appreciation Rights · Derivative | 132,004 | $0.00 Strike: $31.40 | $0.00 |
DisclosureSEC source: 0001209191-22-028631 · doc4a.xml · derivative · entry 6 Kurdikar Devdatt · CIK 0001910621 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 690,967 Underlying: Common Stock · 132,004 shares Expires 2032-04-04 F6 · shares: This Form 4 is being amended to reflect a recalculation of the SARs that the reporting person received on April 4, 2022 in connection with Embecta's spinoff from BD. F7 · derivative.exercise_date: The SARs vest in four annual installments beginning April 4, 2023. Read SEC document |
| April 04, 2022 Filed May 12, 2022 22:28 UTC Amendment | Embecta Corp. EMBC · Entity 5950 | GrantStock Appreciation Rights · Derivative | 217,799 | $0.00 Strike: $31.40 | $0.00 |
DisclosureSEC source: 0001209191-22-028631 · doc4a.xml · derivative · entry 5 Kurdikar Devdatt · CIK 0001910621 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 558,963 Underlying: Common Stock · 217,799 shares Expires 2032-04-04 F6 · shares: This Form 4 is being amended to reflect a recalculation of the SARs that the reporting person received on April 4, 2022 in connection with Embecta's spinoff from BD. Read SEC document |
| April 04, 2022 Filed May 12, 2022 22:28 UTC Amendment | Embecta Corp. EMBC · Entity 5950 | GrantCommon Stock | 27,653 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-028631 · doc4a.xml · nonDerivative · entry 2 Kurdikar Devdatt · CIK 0001910621 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,630 F1 · shares: This Form 4 is being amended to reflect a recalculation of the Time Vested Units ("TVUs") that the reporting person received on April 4, 2022 in connection with Embecta's spinoff from Becton, Dickinson and Company ("BD") on April 1, 2022. Read SEC document |
| April 04, 2022 Filed May 12, 2022 22:28 UTC Amendment | Embecta Corp. EMBC · Entity 5950 | GrantCommon Stock | 71,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-028631 · doc4a.xml · nonDerivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,977 F1 · shares: This Form 4 is being amended to reflect a recalculation of the Time Vested Units ("TVUs") that the reporting person received on April 4, 2022 in connection with Embecta's spinoff from Becton, Dickinson and Company ("BD") on April 1, 2022. F2 · balance_after: This Form 4 now includes 38,395 TVUs and 30,262 performance share units ("PSUs") that were received by the reporting person when he was employed by BD, which were later converted to Embecta TVUs in connection with Embecta's spinoff from BD on April 1, 2022, as well as 70 shares of Embecta that the reporting person received as a dividend in connection with the spinoff. Read SEC document |
| April 01, 2022 Filed May 12, 2022 22:28 UTC Amendment | Embecta Corp. EMBC · Entity 5950 | OtherStock Appreciation Rights · Derivative | 208,293 | $0.00 Strike: $28.31 | $0.00 |
DisclosureSEC source: 0001209191-22-028631 · doc4a.xml · derivative · entry 4 Kurdikar Devdatt · CIK 0001910621 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 341,164 Underlying: Common Stock · 208,293 shares Expires 2031-11-26 F3 · shares: This Form 4 now includes Stock Appreciation Rights ("SARs") that were received by the reporting person when he was employed by BD, which were later converted to Embecta SARs in connection with Embecta's spinoff from BD on April 1, 2022. F5 · derivative.exercise_date: The SARs vest in four annual installments beginning November 26, 2022. Read SEC document |
| April 01, 2022 Filed May 12, 2022 22:28 UTC Amendment | Embecta Corp. EMBC · Entity 5950 | OtherStock Appreciation Rights · Derivative | 132,871 | $0.00 Strike: $29.27 | $0.00 |
DisclosureSEC source: 0001209191-22-028631 · doc4a.xml · derivative · entry 3 Kurdikar Devdatt · CIK 0001910621 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,871 Underlying: Common Stock · 132,871 shares Expires 2031-02-12 F3 · shares: This Form 4 now includes Stock Appreciation Rights ("SARs") that were received by the reporting person when he was employed by BD, which were later converted to Embecta SARs in connection with Embecta's spinoff from BD on April 1, 2022. F4 · derivative.exercise_date: The SARs vest in four annual installments beginning February 11, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.